CTX001 Trademark

Trademark Overview


On Tuesday, February 15, 2022, a trademark application was filed for CTX001 with the United States Patent and Trademark Office. The USPTO has given the CTX001 trademark a serial number of 97267617. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, March 7, 2023. This trademark is owned by Vertex Pharmaceuticals Incorporated. The CTX001 trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia

Providing health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders

Providing medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders
ctx001

General Information


Serial Number97267617
Word MarkCTX001
Filing DateTuesday, February 15, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, March 7, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations primarily comprising cells for the treatment of sickle cell disease; Pharmaceutical preparations primarily comprising cells for the treatment of beta thalassemia
Pseudo MarkCTX ZERO ZERO ONE
Goods and ServicesProviding health information to patients, caregivers and health care professionals; providing health care information relating to blood disorders, and information relating to the therapeutic properties of pharmaceuticals used for treating blood disorders
Goods and ServicesProviding medical and scientific research information in the field of blood disorders, and in the field of pharmaceuticals for treating blood disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, March 7, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, March 7, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, March 7, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 15, 2022NON-FINAL ACTION E-MAILED
Monday, August 15, 2022NON-FINAL ACTION WRITTEN
Monday, August 8, 2022ASSIGNED TO EXAMINER
Sunday, April 10, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Sunday, April 10, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 18, 2022NEW APPLICATION ENTERED